iBet uBet web content aggregator. Adding the entire web to your favor.
iBet uBet web content aggregator. Adding the entire web to your favor.



Link to original content: http://www.ncbi.nlm.nih.gov/pubmed/25061569
Aβ and tau toxicities in Alzheimer's are linked via oxidative stress-induced p38 activation: protective role of vitamin E - PubMed Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2014 Mar 10:2:873-7.
doi: 10.1016/j.redox.2014.03.002. eCollection 2014.

Aβ and tau toxicities in Alzheimer's are linked via oxidative stress-induced p38 activation: protective role of vitamin E

E Giraldo  1 , A Lloret  1 , T Fuchsberger  1 , J Viña  1
Affiliations

Aβ and tau toxicities in Alzheimer's are linked via oxidative stress-induced p38 activation: protective role of vitamin E

E Giraldo et al. Redox Biol. .

Abstract

Oxidative stress is a hallmark of Alzheimer's disease (AD). We propose that rather than causing damage because of the action of free radicals, oxidative stress deranges signaling pathways leading to tau hyperphosphorylation, a hallmark of the disease. Indeed, incubation of neurons in culture with 5 µM beta-amyloid peptide (Aβ) causes an activation of p38 MAPK (p38) that leads to tau hyperphosphorylation. Inhibition of p38 prevents Aβ-induced tau phosphorylation. Aβ-induced effects are prevented when neurons are co-incubated with trolox (the water-soluble analog of vitamin E). We have confirmed these results in vivo, in APP/PS1 double transgenic mice of AD. We have found that APP/PS1 transgenic mice exhibit a high level of P-p38 in the hippocampus but not in cortex and this is prevented by feeding animals with a diet supplemented with vitamin E. Our results underpin the role of oxidative stress in the altered cell signaling in AD pathology and suggest that antioxidant prevention may be useful in AD therapeutics.

Keywords: Antioxidant; Beta-amyloid; P-p38; Vitamin E.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Trolox prevents Aβ dependent p38 activation in neurons in primary culture. Representative Western blots are shown. In all cases, values are means ± SD of 9 experiments. Data were normalized with tubulin values. **p < 0.01 compared to control values; ++p< 0.01 compared to values obtained with Aβ.
Fig. 2
Fig. 2
Vitamin E supplementation prevents activation of p38 in AD mice in vivo. Representative Western blots are shown. In all cases, values are means ± SD of 9 mice (A) or 6 mice (B). Data were normalized with tubulin values, *p < 0.05 compared to values found in wild type mice (WT) or in mice fed with standard diet (TG).
Fig. 3
Fig. 3
P38 activation leads to an increase in p-tau. Cultured neurons were pre-incubated with a p38 inhibitor (SB203580) for 30 min. Prior to the treatment with 5 µM of Aβ. Results showed that when p38 is inhibited there is a decrease in tau-phosphorylation compared to neurons without p38 inhibitor. Representative Western blots are shown. In all cases, values are means ± SD of 4 experiments. **p < 0.01 compared to control values. +p < 0.05 compared to values obtained with Aβ.
Fig. 4
Fig. 4
Effect of Aβ peptide and trolox in the expression of p-tau. Cultured neurons treated with 5 µM of Aβ showed significantly higher expression of p-tau (p < 0.05). Trolox reverted the Aβ-induced effects. Representative Western blots are shown. In all cases, values are means ± SD of 9 experiments. **p < 0.05 compared to control values. +p < 0.05 compared to values obtained with Aβ.
Fig. 5
Fig. 5
P-tau in AD mice model. P-tau was higher in the hippocampus of AD transgenic mice compared to wild type mice. Representative Western blots are shown. In all cases, values are means ± SD of 9 experiments. *p < 0.05 compared to WT animals.
Fig. 6
Fig. 6
Schematic representation of the role of oxidative stress linking Aβ and tau toxicities. Numbers near the arrows indicate the pertinent reference in the reference list. Figures refer to those in the paper.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Ashwell J.D. The many paths to p38 mitogen-activated protein kinase activation in the immune system. Nature Reviews. Immunology. 2006;6:532–540. 16799472 - PubMed
    1. Hensley K., Floyd R.A., Zheng N.Y., Nael R., Robinson K.A., Nguyen X., Pye Q.N., Stewart C.A., Geddes J., Markesbery W.R. p38 kinase is activated in the Alzheimer’s disease brain. Journal of Neurochemistry. 1999;72:2053–2058. 10217284 - PubMed
    1. Pei J.J., Braak E., Braak H., Grundke-Iqbal I., Iqbal K., Winblad B., Cowburn R.F. Localization of active forms of c-Jun kinase (JNK) and p38 kinase in Alzheimer’s disease brains at different stages of neurofibrillary degeneration. Journal of Alzheimer’s Disease. 2001;3:41–48. 12214071 - PubMed
    1. Sun A., Liu M., Nguyen X.V., Bing G. P38 MAP kinase is activated at early stages in Alzheimer’s disease brain. Experimental Neurology. 2003;183:394–405. 14552880 - PubMed
    1. Sheng J.G., Jones R.A., Zhou X.Q., McGinness J.M., Van Eldik L.J., Mrak R.E., Griffin W.S. Interleukin-1 promotion of MAPK-p38 overexpression in experimental animals and in Alzheimer’s disease: potential significance for Tau protein phosphorylation. Neurochemistry International. 2001;39:341–348. 11578769 - PMC - PubMed

Publication types

MeSH terms